Page 6 - Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
AMRX Amneal Pharmaceuticals	US$7.54	12.5%	91.9%	US$2.4b	US$9.67	PE-13.4x	E139.5%	0%
APGE Apogee Therapeutics	US$44.46	8.7%	97.2%	US$2.4b	US$84.83	PB3.2x	E-26.1%	n/a
PTGX Protagonist Therapeutics	US$40.60	13.4%	113.1%	US$2.3b	US$47.00	PE14.1x	E-23.9%	n/a
CGON CG Oncology	US$32.90	6.1%	n/a	US$2.3b	US$68.00	PS4094.3x	E5.1%	n/a
FTRE Fortrea Holdings	US$20.04	-21.7%	-25.5%	US$2.2b	US$29.68	PB1.1x	E61.1%	n/a
VCYT Veracyte	US$29.92	42.5%	18.0%	US$2.2b	US$32.50	PS5.8x	E114.7%	n/a
VCEL Vericel	US$45.45	-0.9%	41.4%	US$2.2b	US$56.63	PE2824.4x	E51.7%	n/a
DCPH Deciphera Pharmaceuticals	US$25.59	0.08%	76.5%	US$2.2b	US$26.85	PS12.7x	E50.6%	n/a
CPRX Catalyst Pharmaceuticals	US$19.30	24.6%	29.9%	US$2.2b	US$30.14	PE33.6x	E20.9%	n/a
CLDX Celldex Therapeutics	US$33.46	2.3%	7.7%	US$2.2b	US$66.78	PS267.1x	E2.3%	n/a
NTLA Intellia Therapeutics	US$21.77	-2.5%	-44.1%	US$2.2b	US$70.18	PS48.1x	E35.7%	n/a
MRVI Maravai LifeSciences Holdings	US$8.70	-5.3%	-13.4%	US$2.2b	US$11.10	PS4.4x	E99.0%	n/a
AMPH Amphastar Pharmaceuticals	US$43.25	7.0%	-20.0%	US$2.1b	US$59.80	PE12.6x	E14.1%	n/a
BHC Bausch Health Companies	US$5.41	3.4%	-35.7%	US$2.0b	US$7.79	PE-4.2x	E118.9%	n/a
VERA Vera Therapeutics	US$35.84	-0.4%	101.3%	US$2.0b	US$57.00	PB6x	E23.0%	n/a
BEAM Beam Therapeutics	US$23.98	-6.4%	-4.9%	US$1.9b	US$50.14	PS5.4x	E-11.3%	n/a
HRMY Harmony Biosciences Holdings	US$33.41	8.1%	3.1%	US$1.9b	US$43.50	PE16.5x	E35.0%	n/a
MIRM Mirum Pharmaceuticals	US$44.74	16.2%	73.1%	US$1.9b	US$59.27	PS8.1x	E69.8%	n/a
JANX Janux Therapeutics	US$36.60	-1.7%	192.1%	US$1.9b	US$62.33	PS126.2x	E-19.0%	n/a
IMCR Immunocore Holdings	US$37.63	1.5%	-38.0%	US$1.9b	US$81.22	PS6.7x	E13.5%	n/a
NVAX Novavax	US$11.85	4.1%	63.7%	US$1.9b	US$18.17	PS1.9x	E76.9%	n/a
VRNA Verona Pharma	US$24.68	22.4%	34.1%	US$1.8b	US$36.50	PB8.9x	E63.2%	n/a
FUSN Fusion Pharmaceuticals	US$21.55	0.4%	332.7%	US$1.8b	US$21.10	PS898.6x	E0.1%	n/a
LGND Ligand Pharmaceuticals	US$99.60	1.5%	48.3%	US$1.8b	US$124.00	PE43.2x	E25.6%	n/a